Title:
ANTIBODIES TO SARS-CORONAVIRUS (COVID-19) S1 SPIKE PROTEIN
Document Type and Number:
WIPO Patent Application WO/2021/207962
Kind Code:
A1
Abstract:
Provided are recombinant monoclonal antibodies that bind to the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2 or COVID-19) spike protein and using methods thereof. The antibodies can inhibit or neutralize SARS-CoV-2 activity, thus can be used for treating or preventing or diagnosing COVID-19 infection in humans.
Inventors:
LU YANAN (CN)
LAN FEI (CN)
XU JIANQING (CN)
ZHAO XI (CN)
DING LONGFEI (CN)
WANG YONGHENG (CN)
WAN JINKAI (CN)
XING SHENGHUI (CN)
FERNANDEZ JOSEPH (US)
LAN FEI (CN)
XU JIANQING (CN)
ZHAO XI (CN)
DING LONGFEI (CN)
WANG YONGHENG (CN)
WAN JINKAI (CN)
XING SHENGHUI (CN)
FERNANDEZ JOSEPH (US)
Application Number:
PCT/CN2020/084857
Publication Date:
October 21, 2021
Filing Date:
April 15, 2020
Export Citation:
Assignee:
ACTIVE MOTIF SHANGHAI LTD (CN)
UNIV FUDAN (CN)
SHANGHAI PUBLIC HEALTH CLINICAL CT (CN)
UNIV FUDAN (CN)
SHANGHAI PUBLIC HEALTH CLINICAL CT (CN)
International Classes:
C07K16/10; A61K39/00; A61P31/14; C12N15/13; C12N15/63; C12P21/08; G01N33/53; G01N33/569
Foreign References:
| CN1914226A | 2007-02-14 | |||
| CN101098710A | 2008-01-02 | |||
| CN1562365A | 2005-01-12 |
Other References:
著 · 论, PENG HAO-RAN, JIANG LIANG-LIANG, YAN-HUA HE, AI-JUN XIAO, TANG HAI-LIN, ZHONG-TIAN QI, PING ZHAO: "Preparation and verification of severe acute respiratory syndrome coronavirus 2 pseudoparticles", ACADEMIC JOURNAL OF SECOND MILITARY MEDICAL UNIVERSITY, vol. 41, no. 4, 1 January 2020 (2020-01-01), XP055864008, DOI: 10.16781/j.0258-879x.2020.04.0359
Attorney, Agent or Firm:
AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
Previous Patent: STAND-ALONE SIDELINK COMMUNICATION OVER UNLICENSED BAND
Next Patent: USER EQUIPMENT RECEIVER BASED DOWNLINK CHANNEL REPETITION
Next Patent: USER EQUIPMENT RECEIVER BASED DOWNLINK CHANNEL REPETITION